<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2299">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04316949</url>
  </required_header>
  <id_info>
    <org_study_id>PREDI-CO</org_study_id>
    <nct_id>NCT04316949</nct_id>
  </id_info>
  <brief_title>Predictors of Respiratory Failure in SARS-Cov-2 Infection</brief_title>
  <official_title>Predictors of Respiratory Failure Requiring ICU Admission Among Hospitalized Patients With SARS-Cov-2 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bologna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The emergence of SARS-CoV-2 is currently engaging and consuming most of resources of
      efficient healthcare systems in Europe, and several hospitals are currently experiencing a
      shortage of ICU beds for critically-ill patients with SARS-CoV-2 pneumonia.

      A risk stratification based on clinical, radiological and laboratory parameters seems
      necessary in order to better identify those patients who may need ICU admission and/or those
      who may benefit from a prompt antiviral therapy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will compared patients with and without respiratory failure in order to find risk
      factors for need for ICU admission. A simple score based on risk factors will be created from
      a multicenter Italian cohort and validated in a multicenter international cohort.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory failure</measure>
    <time_frame>14 days</time_frame>
    <description>Composite of ICU admission or SpO2&lt;92% with 100% FiO2 of oxygen treatment (reservoir mask or CPAP or NIV), respiratory rate &gt;30 bpm, respiratory distress</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurence of bacterial superinfection</measure>
    <time_frame>14 days</time_frame>
    <description>Incidence of bacterial superinfection among ventilated patients with SARS-CoV-2 pneumonia</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>SARS-CoV-2 Pneumonia</condition>
  <arm_group>
    <arm_group_label>Derivation cohort</arm_group_label>
    <description>Derivation cohort: Italian retrospective cohort of all consecutive hospitalized patients with SARS-CoV-2 pneumonia in the participating centers, from February 20 to March 19 2020.
.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Validation cohort</arm_group_label>
    <description>Validation cohort: European and non-European retrospective cohort of all consecutive hospitalized patients with SARS-CoV-2 pneumonia in the participating centers, from March 19 to April 18 2020.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The population of the study will include all consecutive hospitalized patients with
        microbiologically confirmed diagnosis of SARS-CoV-2 infection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalized patients with microbiologically confirmed diagnosis of SARS-CoV-2
             infection

          -  Age &gt; 17 years

        Exclusion Criteria:

          -  Invasive mechanical ventilation within 12 hours from hospital admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Bologna - Department of Medical and Surgical Sciences</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierluigi Viale, MD</last_name>
      <phone>+ 39 051 214 3018</phone>
      <email>pierluigi.viale@unibo.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 19, 2020</study_first_submitted>
  <study_first_submitted_qc>March 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 20, 2020</study_first_posted>
  <last_update_submitted>April 5, 2020</last_update_submitted>
  <last_update_submitted_qc>April 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bologna</investigator_affiliation>
    <investigator_full_name>Michele Bartoletti</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Participant from other centers may request to analyze the registry for other purposes upon IRB and study group approval</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

